NEWS

CEO, Dr. Vlad Bogin collaborates on a scientific publication describing stem cell treatment of a spinal cord injury patient ABSTRACT: Cellular therapy for spinal cord injury (SCI) is overviewed focusing on bone marrow mononuclear cells, olfactory ensheathing cells, and mesenchymal stem cells. A case is made for the possibility of combining cell types, as well as for allogeneic use. We report the case of 29 year old male who suffered a crush fracture of

CEO, Dr. Vlad Bogin collaborates on a scientific publication describing new gene responsible for heart damage in diabetics

Cromos Pharma profiled in The Top 20 Contract Research Organizations in Europe in Research and Markets